7th Circ. Backs TRT-Maker Actavis In Man's Heart Attack Suit

By Henrik Nilsson (June 20, 2023, 8:57 PM EDT) -- The Seventh Circuit on Tuesday affirmed a lower court's ruling not to give a new trial to a man who opted out of a global settlement with Actavis over allegations that the company's testosterone replacement drug caused heart attacks, saying that newly surfaced research documents did not favor him....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!